Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
AJR. American Journal of Roentgenology|March 15, 2023
Prospective Pilot Study of <sup>18</sup>F-Fluoroestradiol PET/CT in Patients With Invasive Lobular CarcinomasMatthew F Covington, John M Hoffman, Kathryn A Morton, et al.Biorxiv : the Preprint Server for Biology|October 24, 2023
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancerYinshen Wee, Junhua Wang, Emily C Wilson, et al.BMC Cancer|May 7, 2021
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarkerKristen C Kelley, Kenneth F Grossman, Mary Brittain-Blankenship, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2015
Efficacy of a Telehealth Intervention on Colonoscopy Uptake When Cost Is a Barrier: The Family CARE Cluster Randomized Controlled TrialLaurie E Steffen, Kenneth M Boucher, Barbara H Damron, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trialAnita Y Kinney, Watcharaporn Boonyasiriwat, Scott T Walters, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 4, 2018
A functional assay-based procedure to classify mismatch repair gene variants in Lynch syndromeMark Drost, Yvonne Tiersma, Bryony A Thompson, et al.Cancer|March 9, 2018
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNANeeraj Agarwal, Sumanta K Pal, Andrew W Hahn, et al.Clinical Genitourinary Cancer|November 14, 2013
Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinomaNeeraj Agarwal, Joaquim Bellmunt, Benjamin L Maughan, et al.Journal for Immunotherapy of Cancer|September 17, 2025
Germline whole-exome sequencing reveals <i>FOXP3</i>-related gene variants conferring urinary cancer susceptibility and associated with immune escapeBing-Jian Feng, Wendy Kohlmann, David A Nix, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.Pageof 13